Education: MD, PhD
University of Nebraska Medical Center, 2000
Dr. Weekes initially trained at the University of Nebraska Medical Center where he completed a combined M.D., Ph.D program. His graduate training was in cell biology and focused on lymphoma cell chemotherapy resistance. Following completion of medical school, he matriculated through a internal medicine residency at the University of Alabama Birmingham. Dr. Weekes focused on the translational research in the development of novel therapies for pancreatic cancer during my medical oncology fellowship at Johns Hopkins Hospital.
Dr. Weekes has an active clinic focused on the management of all gastrointestinal malignancies and early phase clinical studies as part of the developmental therapeutics clinic. In addition, he directs a translational research laboratory focused on developing therapies targeting the tumor microenvironment for the treatment GI malignancies. Dr Weekes is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) as well as the Pancreatic Cancer Research Team.
Sharp J.G., Mann S.L., Murphy B.O., Weekes, C.D.: Culture Methods for the Detection of Minimal Tumor Contamination of Hematopoietic Harvests: A Review. J of Hematotherapy 4:141,1995.
Weekes CD, Pirrucello SJ, Vose JM, Kuszynski C and Sharp JG. Lymphoma Cells Associated with Bone Marrow Stromal Cells in Culture Exhibit Altered Growth and Survival. Leukemia and Lymphoma. 31:151, 1998.
Weekes CD, Kuszynski C and Sharp JG. VLA-4 Mediated Adhesion to Bone Marrow Stromal Cells confers Chemoresistance to Adherent Lymphoma Cells. Leukemia and Lymphoma. 40:631, 2001.
Weekes CD, Vose JM, Lynch JC, Weisenburger DD, et.al. Hodgkin’s Disease in the Elderly – Improved Treatment Outcome with A Doxorubicin-Containing Regimen. J.Clin. Oncol. 20:1087, 2002.